Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | RVTY | TMO |
|---|
| Close | 157.00 | 697.00 |
| Market Cap | $17.4B | $258B |
| 1M | +2.69% | +3.25% |
| P/E (TTM) | 73.7 | 36.4 |
| Forward P/E | 25.0 | 24.6 |
| P/E 5-Yr Percentile | 83 | 78 |
| P/S | 6.0 | 5.4 |
| P/B | 2.4 | 4.7 |
| Dividend Yield | 0.31% | 0.29% |
| Latest Quarter Revenue | $730M | $12.1B |
| Revenue YoY | +1.3% | +9.1% |
| Gross Margin | 57.1% | — |
| Latest Quarter EPS | 0.47 | 4.64 |
| Avg Post-Earnings Move | ±2.4% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.91% | 1.82% |
| 90-Day Net Insider Buying | −$1.3M | −$40.3M |
RVTY · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
